Adult-to-adult living donor liver transplantation at the Asan Medical Center, Korea.
Between February 1997 and December 2001, 311 adult-to-adult living donor liver transplants (A-A LDLTs) were performed at the Asan Medical Center for patients above 20 years of age. Indications for A-A LDLT were: chronic hepatitis B (203), chronic hepatitis C (5), hepatocellular carcinoma (64), alcoholic cirrhosis (9), cryptogenic cirrhosis (4), secondary biliary cirrhosis (5), primary biliary cirrhosis (1), Wilson' s disease (2), autoimmune hepatitis (1), hepatic tuberculosis (1), cholangiocarcinoma (1), fulminant hepatic failure (14) and primary non-function of cadaveric liver graft (1). Of 311 A-A LDLTs, 36 were of medical high urgency, 20 were for acute and subacute hepatic failure, 15 were for hepato-renal syndrome and 1 was for primary non-function. Recipient age ranged from 27 to 64 years. Donor age ranged from 16 to 62 years. There was no donor mortality. Implanted liver grafts were categorized into seven types: 175 modified right lobe (MRL), 70 left lobe, 32 right lobe, 20 dual grafts, 10 left lobe plus caudate lobe, three extended right lobe and one posterior segment. In MRL, the tributaries of the middle hepatic vein were reconstructed by interpositioning a vein graft. Indication for dual graft implantation was the same as single graft A-A LDLT, and four of 20 were emergency cases. Of 20 dual grafts, 14 received two left lobes, four received a left lobe and a lateral segment, one received a right lobe and a left lobe and one received a lateral segment and a posterior segment. Graft volume ranged from 28% to 83% of the standard liver volume of the recipients. There were 33 (10.6%) in-hospital mortalities (< 4 months) among the 310 patients after 311 A-A LDLTs. Of the 36 patients receiving emergency transplants, 31 survived. These encouraging results justify the expansion of A-A LDLT in coping with increasing demands, even in urgent situations. We have aimed to introduce the establishment of the efficacy of A-A LDLT in various end-stage chronic and acute liver diseases, as well as new technical advances to overcome small graft-size syndrome by using dual-graft implantation and MRL, both of which were first developed in our department.
Lee
S G
SG
Department of General Surgery, Asan Medical Center, Ulsan University Medical School, Seoul, Korea. sglee2@amc.seoul.kr
Park
K M
KM
Hwang
S
S
Lee
Y J
YJ
Kim
K H
KH
Ahn
C S
CS
Choi
D L
DL
Joo
S H
SH
Jeon
J Y
JY
Chu
C W
CW
Moon
D B
DB
Min
P C
PC
Koh
K S
KS
Han
S H
SH
Park
S H
SH
Choi
G T
GT
Hwang
K S
KS
Lee
E J
EJ
Chung
Y H
YH
Lee
Y S
YS
Lee
H J
HJ
Kim
M H
MH
Lee
S K
SK
Suh
D J
DJ
Kim
J J
JJ
Sung
K B
KB
D000328:Adult; D002102:Cadaver; D017052:Hospital Mortality; D006801:Humans; D007723:Korea / Q000453:epidemiology; D008107:Liver Diseases / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods / Q000706:statistics & numerical data; D019520:Living Donors / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000401:mortality; D014019:Tissue Donors